טוען...
Improving and maintaining responses in pediatric B-ALL CAR-T therapy
CAR T therapy has heralded a new era in the treatment of acute lymphoblastic leukemia (ALL) and other hematologic malignancies. In this autologous immunotherapy, patient derived T cells are genetically engineered and then infused back to kill the leukemia cells. The observed response rates in ALL ar...
שמור ב:
| הוצא לאור ב: | Cancer J |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130572/ https://ncbi.nlm.nih.gov/pubmed/33750075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000513 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|